Connection
Christine Fisher to HLA-A2 Antigen
This is a "connection" page, showing publications Christine Fisher has written about HLA-A2 Antigen.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.032 |
|
|
|
-
Hueman MT, Dehqanzada ZA, Novak TE, Gurney JM, Woll MM, Ryan GB, Storrer CE, Fisher C, McLeod DG, Ioannides CG, Ponniah S, Peoples GE. Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients. Clin Cancer Res. 2005 Oct 15; 11(20):7470-9.
Score: 0.016
-
Peoples GE, Gurney JM, Hueman MT, Woll MM, Ryan GB, Storrer CE, Fisher C, Shriver CD, Ioannides CG, Ponniah S. Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients. J Clin Oncol. 2005 Oct 20; 23(30):7536-45.
Score: 0.016